YSCH-01
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for YSCH-01, covering 2026-04-20 to 2026-04-20. Get the full timeline:
Most recent: Clinical Trial Update: Evaluating Safety, Tolerability, and Preliminary Efficacy of YSCH-01 Monotherapy and in Combination With Atezolizumab for Recurrent Glioblastoma [EARLY_Phase 1]